Calcium intake and risk of primary hyperparathyroidism in women: prospective cohort study
- PMID: 23080543
- PMCID: PMC3475985
- DOI: 10.1136/bmj.e6390
Calcium intake and risk of primary hyperparathyroidism in women: prospective cohort study
Abstract
Objective: To examine the association between calcium intake and risk of primary hyperparathyroidism in women.
Design: Prospective cohort study.
Setting: Nurses' Health Study I, which originally recruited participants from the 11 most populous states in the United States.
Participants: 58,354 female registered nurses enrolled in the Nurses' Health Study I aged 39-66 years in 1986 and with no history of primary hyperparathyroidism. Calcium intake was assessed every four years using semiquantitative questionnaires on food frequency.
Main outcome measure: Incident primary hyperparathyroidism, confirmed by medical record review.
Results: During 22 years of follow-up, we recorded 277 incident cases of primary hyperparathyroidism. Women were divided into five equal groups, according to intake of dietary calcium. After adjusting for age, body mass index, race, and other factors, the relative risk of primary hyperparathyroidism for women in the group with the highest intake of dietary calcium was 0.56 (95% confidence interval 0.37 to 0.86, P=0.009 for trend), compared with the group with the lowest intake. The multivariable relative risk of primary hyperparathyroidism for women taking more than 500 mg/day of calcium supplements compared with no calcium supplements was 0.41 (95% confidence interval 0.29 to 0.60, P<0.001 for trend). Analyses restricted to participants with regular physical exams did not significantly change the association between calcium intake and risk of primary hyperparathyroidism.
Conclusion: Increased calcium intake is independently associated with a reduced risk of primary hyperparathyroidism in women.
Conflict of interest statement
Competing interests: All authors have completed the Unified Competing Interest form at
Comment in
-
Increased calcium intake may reduce risk of primary hyperparathyroidism.BMJ. 2012 Oct 17;345:e6646. doi: 10.1136/bmj.e6646. BMJ. 2012. PMID: 23080544 No abstract available.
Similar articles
-
Increased calcium intake may reduce risk of primary hyperparathyroidism.BMJ. 2012 Oct 17;345:e6646. doi: 10.1136/bmj.e6646. BMJ. 2012. PMID: 23080544 No abstract available.
-
Calcium supplement intake and risk of cardiovascular disease in women.Osteoporos Int. 2014 Aug;25(8):2047-56. doi: 10.1007/s00198-014-2732-3. Epub 2014 May 7. Osteoporos Int. 2014. PMID: 24803331 Free PMC article.
-
Folate intake and the risk of incident hypertension among US women.JAMA. 2005 Jan 19;293(3):320-9. doi: 10.1001/jama.293.3.320. JAMA. 2005. PMID: 15657325
-
Inadequate dietary calcium and vitamin D intakes in renal-transplant recipients in Ireland.J Ren Nutr. 2007 Nov;17(6):408-15. doi: 10.1053/j.jrn.2007.05.005. J Ren Nutr. 2007. PMID: 17971313
-
Effectiveness and safety of vitamin D in relation to bone health.Evid Rep Technol Assess (Full Rep). 2007 Aug;(158):1-235. Evid Rep Technol Assess (Full Rep). 2007. PMID: 18088161 Free PMC article. Review.
Cited by
-
[Registries of parathyroid glands diseases in the Russian Federation].Probl Endokrinol (Mosk). 2021 Aug 19;67(4):4-7. doi: 10.14341/probl12803. Probl Endokrinol (Mosk). 2021. PMID: 34533008 Free PMC article. Russian.
-
Primary Hyperparathyroidism: A Narrative Review of Diagnosis and Medical Management.J Clin Med. 2021 Apr 9;10(8):1604. doi: 10.3390/jcm10081604. J Clin Med. 2021. PMID: 33918966 Free PMC article. Review.
-
[Asymptomatic primary hyperparathyroidism : Operation or observation?].Internist (Berl). 2021 May;62(5):496-504. doi: 10.1007/s00108-021-00996-0. Epub 2021 Mar 12. Internist (Berl). 2021. PMID: 33710361 Review. German.
-
Evaluation of Serum Level of FGF23 and 1,25(OH)2D3 in Primary Hyperparathyroidism Patients Before and After Parathyroidectomy.Int J Gen Med. 2020 Jun 11;13:289-295. doi: 10.2147/IJGM.S253246. eCollection 2020. Int J Gen Med. 2020. PMID: 32606893 Free PMC article.
-
Primary Hyperparathyroidism.J Clin Endocrinol Metab. 2018 Nov 1;103(11):3993-4004. doi: 10.1210/jc.2018-01225. J Clin Endocrinol Metab. 2018. PMID: 30060226 Free PMC article. Review.
References
-
- Marcocci C, Cetani F. Clinical practice. Primary hyperparathyroidism. N Engl J Med 2011;365:2389-97. - PubMed
-
- NIH conference. Diagnosis and management of asymptomatic primary hyperparathyroidism: consensus development conference statement. Ann Intern Med 1991;114:593-7. - PubMed
-
- Jorde R, Bonaa KH, Sundsfjord J. Primary hyperparathyroidism detected in a health screening: the Tromso study. J Clin Epidemiol 2000;53:1164-9. - PubMed
-
- Lundgren E, Hagstrom EG, Lundin J, Winnerback K, Roos J, Ljunghall S, et al. Primary hyperparathyroidism revisited in menopausal women with serum calcium in the upper normal range at population-based screening 8 years ago. World J Surg 2002;26:931-6. - PubMed
-
- Ruda JM, Hollenbeak CS, Stack BC Jr. A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003. Otolaryngol Head Neck Surg 2005;132:359-72. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical